Jean‐Charles Nault
About
Jean‐Charles Nault is a scholar working on Hepatology, Epidemiology and Cancer Research.
According to data from OpenAlex, Jean‐Charles Nault has authored 170 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Hepatology, 71 papers in Epidemiology and 34 papers in Cancer Research. Recurrent topics in Jean‐Charles Nault's work include Hepatocellular Carcinoma Treatment and Prognosis (84 papers), Liver Disease Diagnosis and Treatment (53 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers). Jean‐Charles Nault is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (84 papers), Liver Disease Diagnosis and Treatment (53 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers). Jean‐Charles Nault collaborates with scholars based in France, United States and Italy. Jean‐Charles Nault's co-authors include Jessica Zucman‐Rossi, Augusto Villanueva, Josep M. Llovet, Paulette Bioulac‐Sage, Sandra Rebouissou, Julien Caldéraro, Charles Balabaud, Sandrine Imbeaud, Gabrielle Couchy and Nathalie Ganne‐Carrié and has published in prestigious journals such as Nature Medicine, Nature Communications and Nature Genetics.
In The Last Decade
Jean‐Charles Nault
165 papers receiving 10.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jean‐Charles Nault France | 48 | 4.7k | 3.4k | 2.9k | 2.5k | 2.1k | 170 | 10.3k | ||
| Hui‐Chuan Sun China | 58 | 3.7k 0.8× | 5.0k 1.5× | 2.0k 0.7× | 4.2k 1.7× | 3.1k 1.5× | 308 | 11.8k | ||
| Satdarshan P. Monga United States | 58 | 4.2k 0.9× | 6.9k 2.0× | 2.1k 0.7× | 1.4k 0.6× | 1.6k 0.7× | 229 | 11.7k | ||
| Shinichi Miyagawa Japan | 47 | 4.1k 0.9× | 1.9k 0.6× | 2.3k 0.8× | 1.1k 0.4× | 2.6k 1.2× | 279 | 9.9k | ||
| Sandrine Imbeaud France | 43 | 1.9k 0.4× | 4.2k 1.2× | 1.4k 0.5× | 1.8k 0.7× | 1.3k 0.6× | 90 | 7.8k | ||
| Shoji Nakamori Japan | 55 | 1.6k 0.3× | 3.6k 1.1× | 1.5k 0.5× | 2.0k 0.8× | 4.4k 2.1× | 276 | 10.1k | ||
| Bruno Clément France | 50 | 2.6k 0.6× | 2.6k 0.8× | 1.3k 0.4× | 1.3k 0.5× | 1.4k 0.7× | 183 | 7.8k | ||
| Feng Shen China | 54 | 3.4k 0.7× | 1.9k 0.6× | 2.1k 0.7× | 2.2k 0.9× | 3.5k 1.7× | 299 | 10.1k | ||
| Masato Nakamura Japan | 44 | 1.5k 0.3× | 3.1k 0.9× | 973 0.3× | 1.5k 0.6× | 3.1k 1.4× | 401 | 7.9k | ||
| A. Benedetti Italy | 54 | 3.1k 0.7× | 2.3k 0.7× | 3.3k 1.1× | 495 0.2× | 1.6k 0.8× | 265 | 9.1k | ||
| Jian Zhou China | 39 | 1.8k 0.4× | 2.5k 0.7× | 863 0.3× | 1.8k 0.7× | 2.0k 1.0× | 225 | 6.6k |
Countries citing papers authored by Jean‐Charles Nault
Since
Specialization
Citations
This map shows the geographic impact of Jean‐Charles Nault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Charles Nault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Charles Nault more than expected).
Fields of papers citing papers by Jean‐Charles Nault
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jean‐Charles Nault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Charles Nault. The network helps show where Jean‐Charles Nault may publish in the future.
Co-authorship network of co-authors of Jean‐Charles Nault
This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Charles Nault. A scholar is included among the top collaborators of Jean‐Charles Nault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Charles Nault. Jean‐Charles Nault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Merle, P., Julien Edeline, Karine Le Malicot, et al.. (2025). 1471MO Adding ipilimumab (IPI) to atezolizumab (ATEZO) plus bevacizumab (BEV) in patients (pts) with unresectable hepatocellular carcinoma (uHCC) in first-line systemic therapy (1L): PRODIGE 81/FFCD 2101 - TRIPLET HCC. Annals of Oncology. 36. S822–S822.
2.
Campani, Claudia, Sandrine Imbeaud, Gabrielle Couchy, et al.. (2024). Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Gut. 73(11). 1870–1882.
3.
Merle, Philippe, Jean-Marie Péron, Karine Le Malicot, et al.. (2024). Preliminary safety data of the PRODIGE 81-FFCD 2101-TRIPLET-HCC trial assessing the triple combination atezolizumab-bevacizumab-ipilimumab in patients (pts) treated in systemic therapy for hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 42(16_suppl). e16195–e16195.
4.
Nault, Jean‐Charles, Julien Caldéraro, & Maxime Ronot. (2024). Integration of new technologies in the multidisciplinary approach to primary liver tumours: The next-generation tumour board. Journal of Hepatology. 81(4). 756–762.
5.
Gigante, Elia, Mohamed Bouattour, Hélène Regnault, et al.. (2023). Atezolizumab and bevacizumab for non-resectable or metastatic combined hepatocellular-cholangiocarcinoma: a multicentric retrospective study. Journal of Hepatology. 78. S577–S577.
6.
Campani, Claudia, Sandrine Imbeaud, Marianne Ziol, et al.. (2023). Dynamic evolution of circulating tumor DNA in patients with hepatocellular carcinoma across tumor stages and treatments. Digestive and Liver Disease. 55. S213–S214.
7.
Laurent‐Puig, Pierre, Marianne Ziol, Nathalie Ganne‐Carrié, et al.. (2023). Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab. Journal of Hepatology. 79(6). 1450–1458.
8.
Bayard, Quentin, Camille Péneau, Sandrine Imbeaud, et al.. (2022). Structure, Dynamics, and Impact of Replication Stress–Induced Structural Variants in Hepatocellular Carcinoma. Cancer Research. 82(8). 1470–1481.
9.
Campani, Claudia, Lorraine Blaise, Nathalie Ganne‐Carrié, et al.. (2022). Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab–bevacizumab. Liver International. 43(3). 708–717.
10.
Campani, Claudia & Jean‐Charles Nault. (2022). Molecular mechanisms of liver carcinogenesis related to metabolic syndrome. Hepatoma Research.
11.
Sutton, Angéla, Lorraine Blaise, Olivier Séror, et al.. (2022). Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 9. 1369–1383.
12.
Blaise, Lorraine, Héléna Pereira, Valérie Vilgrain, et al.. (2021). Percutaneous ablation for locally advanced hepatocellular carcinoma with tumor portal invasion. Clinics and Research in Hepatology and Gastroenterology. 45(6). 101731–101731.
13.
Caruso, Stefano, Tiziana La Bella, Sandrine Imbeaud, et al.. (2019). Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response. Gastroenterology. 157(3). 760–776.
14.
Allaire, Manon, Richard Layese, Erwan Guyot, et al.. (2018). Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis. Digestive and Liver Disease. 51(1). 86–94.
15.
Chalaye, Julia, Charlotte Costentin, Alain Luciani, et al.. (2018). Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma. Journal of Hepatology. 69(2). 336–344.
16.
Rebouissou, Sandra, Tiziana La Bella, Sandrine Imbeaud, et al.. (2017). Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro. Clinical Cancer Research. 23(15). 4364–4375.
17.
Nault, Jean‐Charles, Erwan Guyot, Christelle Laguillier, et al.. (2013). Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis. Cancer Epidemiology Biomarkers & Prevention. 22(8). 1343–1352.
18.
Caldéraro, Julien, Jean‐Charles Nault, Paulette Bioulac‐Sage, et al.. (2013). ALDH3A1 is overexpressed in a subset of hepatocellular carcinoma characterised by activation of the Wnt/ß-catenin pathway. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 464(1). 53–60.
19.
Nahon, Pierre, Roland Amathieu, Mohamed N. Triba, et al.. (2012). Identification of Serum Proton NMR Metabolomic Fingerprints Associated with Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis. Clinical Cancer Research. 18(24). 6714–6722.
20.
Nault, Jean‐Charles & J. F. Manville. (1997). Species Differentiation of Two Common Lumber Mixes by Diffuse Reflectance Fourier Transform Infrared (DRIFT) Spectroscopy. Wood and Fiber Science. 29(1). 2–9.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Hui‐Chuan Sun Breakdown of academic impact, for papers by Satdarshan P. Monga Breakdown of academic impact, for papers by Shinichi Miyagawa Breakdown of academic impact, for papers by Sandrine Imbeaud Breakdown of academic impact, for papers by Shoji Nakamori Breakdown of academic impact, for papers by Bruno Clément Breakdown of academic impact, for papers by Feng Shen Breakdown of academic impact, for papers by Masato Nakamura Breakdown of academic impact, for papers by A. Benedetti Breakdown of academic impact, for papers by Jian Zhou